(Press-News.org) Contact information: Robbin Ray
Robbin_Ray@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute
Exercise can reduce drug-related joint pain in breast cancer patients, study shows
SAN ANTONIO— Women being treated with breast cancer drugs known as aromatase inhibitors can markedly ease the joint pain associated with the drugs by engaging in moderate daily exercise, Dana-Farber Cancer Institute and Yale University investigators report in a study to be presented during the San Antonio Breast Cancer Symposium.
The study, scheduled for presentation Thursday, Dec. 12, at 10:00 a.m., CT in San Antonio, Texas, involved 121 postmenopausal women who were taking aromatase inhibitors for breast cancer and who rated their joint pain as mild or greater on a standard pain-evaluation questionnaire. Sixty-one of them were randomly assigned to participate in two supervised strength training sessions a week and to engage in an average of 150 minutes of aerobic exercise a week. The others followed their normal daily activities.
After a year, joint pain scores decreased by 20 percent among the women in the exercise group and by three percent in the other group. The severity of joint pain also decreased significantly more in those who exercised than in those who didn't, as did the degree to which pain interfered with their lives.
"This is one of the first studies to identify an approach – particularly a non-medical approach – that can effectively lower joint pain for these patients," says the study's senior author, Jennifer Ligibel, MD, of the Susan F. Smith Center for Women's Cancers at Dana-Farber. "Exercise offers an attractive option for patients who want to continue taking these drugs but who are burdened by their side effects."
Aromatase inhibitors are recommended for all postmenopausal women with breast cancer categorized as hormone receptor-positive, meaning the cancer cells grow and divide in response to estrogen. The drugs, which prevent other hormones from being converted into estrogen, can reduce the risk of a cancer recurrence.
"Joint pain, or arthralgia, which occurs in up to half of breast cancer patients who take aromatase inhibitors, is one of the major drawbacks of these drugs," Ligibel states. "The pain leads many to discontinue the drugs, which can increase the chance that the cancer will return. Identifying a way to help women tolerate these drugs is a very important finding."
INFORMATION:
The lead author of the study is Melinda Irwin, PhD, MPH, who leads the Yale HOPE (Hormone & Physical Exercise) Study, which recruited the participants in the current study. Co-authors are Brenda Cartmel, PhD, Cary Gross, MD, Elizabeth Ercolano, RN, DNSc, Martha Fiellin, Scott Capozza, Marianna Rothbard, Yang Zhou, PhD, Maura Harrigan, MS, RD, and Tara Sanft, MD, of Yale; Kathryn Schmitz, PhD, MPH, of the University of Pennsylvania; Tuhina Neogi, MD, PhD, of Boston University; and Dawn Hershman, MD, MS, of Columbia University.
About Dana-Farber
Dana-Farber Cancer Institute is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center, designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women's Hospital as Dana-Farber/Brigham and Women's Cancer Center and it provides pediatric care with Boston Children's Hospital as Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber is the top ranked cancer center in New England and fifth nationally, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding.
Follow Dana-Farber on Facebook and Twitter.
Exercise can reduce drug-related joint pain in breast cancer patients, study shows
2013-12-12
ELSE PRESS RELEASES FROM THIS DATE:
Where water is limited, researchers determine how much water is enough
2013-12-12
Where water is limited, researchers determine how much water is enough
Just how thirsty are our crops?
Today, December 12, JoVE, the Journal of Visualized Experiments, has published an environmental research technique that could turn the age-old ...
First test to predict acute mountain sickness
2013-12-12
First test to predict acute mountain sickness
Vulnerable people can modify their behavior and take preventative medication
Istanbul, Turkey – 12 December 2013: The first test to identify acute mountain sickness has been developed by a team of researchers ...
Salmonella jams signals from bacteria-fighting mast cells
2013-12-12
Salmonella jams signals from bacteria-fighting mast cells
DURHAM, N.C. – A protein in Salmonella inactivates mast cells -- critical players in the body's fight against bacteria and other pathogens -- rendering them unable to protect against bacterial ...
Fatty acids crucial to embryonic development
2013-12-12
Fatty acids crucial to embryonic development
Baltimore, MD— One classical question in developmental biology is how different tissue types arise in the correct position of the developing embryo. While one signaling pathway that controls this process has been well ...
Fox Chase study shows families don't understand genetic test results or their implications
2013-12-12
Fox Chase study shows families don't understand genetic test results or their implications
Findings suggest more outreach is needed for family members who may carry their own genetic risks of cancer
PHILADELPHIA (December 12, 2013)—A study done by researchers ...
High levels of maternal care has life-long impact on vulnerability to stress
2013-12-12
High levels of maternal care has life-long impact on vulnerability to stress
Hollywood, FL (December 12, 2013) – A new study shows that high levels of maternal care during the early post-natal period in rodents can reduce the sensitivity of the offspring to ...
Peripheral immune system may regulate vulnerability to depression
2013-12-12
Peripheral immune system may regulate vulnerability to depression
Hollywood, FL (December 12, 2013) – A new study shows that immune cells outside the brain may regulate propensity to develop depression. The data were presented today at the American College of Neuropsychopharmacology ...
Worms and hot baths: Novel approaches to treating autism
2013-12-12
Worms and hot baths: Novel approaches to treating autism
Hollywood, FL (December 12, 2013) – A new study shows that two unusual treatment approaches may have beneficial effects on the symptoms of autism in children and adults with the disorder. Using a hot bath ...
Drug cuts breast cancer cases by more than 50 percent in high risk women
2013-12-12
Drug cuts breast cancer cases by more than 50 percent in high risk women
Taking the breast cancer drug anastrozole for five years reduced the chances of post-menopausal women at high risk of breast cancer developing the disease by 53% compared ...
What the past tells us about modern sea-level rise
2013-12-12
What the past tells us about modern sea-level rise
Researchers from the University of Southampton and the Australian National University report that sea-level rise since the industrial revolution has been fast by natural standards and – at current rates – ...